Log In
Print
BCIQ
Print
Print this Print this
 

volasertib (BI 6727)

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionPolo-like kinase 1 (PLK1; STPK13) inhibitor
Molecular Target Polo-like kinase 1 (PLK1) (STPK13)
Mechanism of ActionPolo-like kinase 1 (PLK1) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today